Research Options for
Pediatric Vitiligo

A child vitiligo study is now enrolling children ages 2–11 with non-segmental vitiligo.

Check if your child qualifies
IRB approved
No Cost to Participate

“You’ve watched your child notice the patches. You’ve answered the questions. You’ve done the research. And you’re still looking for something more.”

If that sounds familiar, you’re not alone. Vitiligo affects millions of children, and for many families, the journey from diagnosis to receiving genuine support can be lengthy and uncertain. 

The study exists because researchers believe children with vitiligo deserve treatment options specifically developed and tested for them. Currently, your family has the opportunity to be part of that work.

What does your family receive?

Participation in clinical research is a personal decision. Here’s what’s included for eligible families in this study.

Check Eligibility

A specialized program

Access to an investigational treatment approach being evaluated specifically for children under 12

Keep on Track

Close care and monitoring from a vitiligo specialist throughout the study

Reimbursements

Compensation for your time and reasonable travel expenses

Unlock answers for their unique skin

The Vitiligo Study (Protocol INC 18424-312) is evaluating the safety and effectiveness of an investigational cream called ruxolitinib — a topical treatment already approved for vitiligo in adults — to see whether it may be safe and helpful for children under 12.
“Investigational” means the cream is being studied in this age group specifically.

Participation helps researchers understand whether this approach can become a real option for children living with vitiligo.

Parents begin by submitting a short eligibility form. A research coordinator then contacts them to explain the study and complete the screening process, including consent. If the child qualifies, they are enrolled and start the study treatment.

Throughout the study, the child attends scheduled visits for monitoring, skin assessments, and progress tracking, while following simple at-home instructions. At the end, a final evaluation and safety follow-up are completed. Participation is voluntary, and families may withdraw at any time.

Your privacy is important to us. Any information you provide through this website or during the eligibility screening process will be kept strictly confidential and used only for the purpose of evaluating potential participation in this research study.

Your child’s personal and medical information will be handled in accordance with applicable privacy laws and research regulations. Submitting your information does not obligate you to participate in the study.

Does your child meet the basic criteria?

Children may be eligible if they meet the following general conditions. A study team member will review your child’s full history during the screening process.

Basic eligibility criteria

Age 2 to 11 years old

Children under 12 years old at the time of enrollment.

Non-segmental vitiligo

White patches that appear on both sides of the body, not limited to one area.

Less than 10% affected.

Vitiligo covers less than 10% of the face and body combined.

Clinical Diagnosis

Your child has been formally diagnosed with non-segmental vitiligo by a doctor.

What happens if we enroll?

We understand your time matters. Here’s what to expect from start to finish.
1

Pre-screening

Complete a short form to see whether your child may be eligible based on basic criteria. No medical records needed at this stage.

2

Screening visit

If the pre-screen looks promising, you’ll meet with the study team in person. They’ll review your child’s history, examine the affected areas, and answer every question you have before any decisions are made.

3

Participation (if eligible)

Enrolled participants apply the investigational cream as directed and attend follow-up visits with the study team. Your child will receive close medical monitoring throughout, from vitiligo specialists.

4

Study Completion

The study team will walk you through what happens after the study ends, including next steps for your child’s ongoing care.

Why participate in a research study?

Clinical research plays a crucial role in providing children with access to new treatments and advancing medical knowledge for future generations. Our mission is to create new opportunities for children and families by advancing research and ensuring that they have access to innovative therapies that have the potential to transform lives.

Dr. Mercedes E. González

Pediatric Dermatology Specialist & Principal Investigator

We are here to provide clarity.

Safety is the study’s top priority. The investigational medication has been studied in adults and is now being evaluated in adolescents. Your teen will be closely monitored with regular bloodwork, vital signs, and clinical assessments. An independent safety committee also reviews data continuously throughout the study.

Families are free to withdraw from the study at any time without consequence. Participation is entirely voluntary.

There is no cost to participate. Study medication, clinic visits, and all study-related lab work are provided at no charge. Participants may also receive compensation for time and travel — please speak with our team for details.

After completing the open-label extension, participants finish a 4-week follow-up visit. Our team will discuss ongoing care options at that time. Data collected will help advance treatment options for adolescents with alopecia areata.

/

Your teen may qualify for this study.

If your child has severe alopecia areata and is between the ages of 12 and 17, find out in less than 2 minutes whether they may be eligible to participate at no cost to your family.

Check Eligibility Now →

It only takes 20 seconds.

© 2026 PEDSKIN Research
All rights reserved

This is a research facility. Treatments are investigational.
Participation is voluntary.